CSI Market
Sign In | Register

Biofrontera Inc (BFRI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access BFRI quarterly Cash Flow →
Tracking cash flow results across Biofrontera Inc to Dec 31 2021 helps illustrate how Dec 31 2025's cash generation has responded to changing business conditions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-10.54
Depreciation & amortization0.14
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed-0.07
Increase (Decrease) in Inventories1.45
R & D, Environmental and Other Expense0.00
Gain (Loss) on Sale of Assets and Asset Impairment Charges-0.70
Share-based Compensation0.95
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction1.25
Operating Lease Right Of Use Asset Amortization Expense0.73
Gain Loss Related To Litigation Settlement-
Warrant Inducement Expense-
Excess Of Warrant Fair Value Over Offering Proceeds-
Loss On Settlement Of Lease Liability-
Noncash Interest Expense-0.68
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-1.91
Accounts Payable0.08
Increase (Decrease) in Other Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-1.73
Other Working Capital-0.69
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.64
Discontinued operations0.00
Net Cash flow from Operating Activities-13.36
Investing Activities
Capital Expenditures0.00
Sale of Capital Items3.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Sale Of Equity Securities Fv Ni-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities3.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock10.85
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Related Party Indebtedness-
Proceeds From Startup Cost Financing-
Proceeds From Exercise Of Warrants-
Proceeds From Issuance Of Exercise Of Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities10.85
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-10.36
Total Cash Flow0.49
4 historic quarters locked

Sign in to unlock the full Biofrontera Inc cash flow history.

Sign In Create Free Account

About Biofrontera Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 19, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-011625

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License